Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 6354
  • Home
  • Print this page
  • Email this page

    Article Cited by others

LETTER TO EDITOR

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity

Azad Rajvardhan, Chandra Parijat

Year : 2007| Volume: 55| Issue : 4 | Page no: 319-319

   This article has been cited by
 
1 Off-label use of intravitreal bevacizumab for severe retinopathy of prematurity
L.E. Alba,R.A. Zaldua,R.A. Masini
Archivos de la Sociedad Española de Oftalmología (English Edition). 2015;
[Pubmed]  [Google Scholar] [DOI]
2 Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease
Marcel N Menke,Carsten Framme,Mathias Nelle,Markus R Berger,Veit Sturm,Sebastian Wolf
BMC Ophthalmology. 2015; 15(1)
[Pubmed]  [Google Scholar] [DOI]
3 Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity
S. G. Tahija,R. Hersetyati,G. C. Lam,S. Kusaka,P. G. McMenamin
British Journal of Ophthalmology. 2014; 98(4): 507
[Pubmed]  [Google Scholar] [DOI]
4 Uso off-label de bevacizumab intravítreo en retinopatía del prematuro severa
L.E. Alba,R.A. Zaldua,R.A. Masini
Archivos de la Sociedad Española de Oftalmología. 2014;
[Pubmed]  [Google Scholar] [DOI]
5 An Updated Study of the Use of Bevacizumab in the Treatment of Patients with Prethreshold Retinopathy of Prematurity in Taiwan
Wei-Chi Wu,Hsi-Kung Kuo,Po-Ting Yeh,Chung-May Yang,Chi-Chun Lai,San-Ni Chen
American Journal of Ophthalmology. 2013; 155(1): 150
[Pubmed]  [Google Scholar] [DOI]
6 Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization
Frank Ong,Jane Kuo,Wei-Chi Wu,Ching-Yu Cheng,Wendell-Lamar Blackwell,Brian Taylor,Wayne Grody,Jerome Rotter,Chi-Chun Lai,Tien Wong
Journal of Personalized Medicine. 2013; 3(1): 40
[Pubmed]  [Google Scholar] [DOI]
7 Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan
Wei-Chi Wu,Po-Ting Yeh,San-Ni Chen,Chung-May Yang,Chi-Chun Lai,Hsi-Kung Kuo
Ophthalmology. 2011; 118(1): 176
[Pubmed]  [Google Scholar] [DOI]
8 Effects and complications of bevacizumab use in patients with retinopathy of prematurity: A multicenter study in Taiwan
Wu, W.-C., Yeh, P.-T., Chen, S.-N., Yang, C.-M., Lai, C.-C., Kuo, H.-K.
Ophthalmology. 2011; 118(1): 176-183
[Pubmed]  [Google Scholar]
9 Long-term tolerability and serum concentration of bevacizumab (avastin) when injected in newborn rabbit eyes
Wu, W.-C., Lai, C.-C., Chen, K.-J., Chen, T.-L., Wang, N.-K., Hwang, Y.-S., Yeung, L., Li, L.-M.
Investigative Ophthalmology and Visual Science. 2010; 51(7): 3701-3708
[Pubmed]  [Google Scholar]
10 Bevacizumab (Avastin) for the Treatment of Ocular Disease
Jonathan B. Gunther,Michael M. Altaweel
Survey of Ophthalmology. 2009; 54(3): 372
[Pubmed]  [Google Scholar] [DOI]
11 Bevacizumab (Avastin) for the Treatment of Ocular Disease
Gunther, J.B., Altaweel, M.M.
Survey of Ophthalmology. 2009; 54(3): 372-400
[Pubmed]  [Google Scholar]
12 Antibodies for therapeutic uses and the evolution of biotechniques
Nieri, P., Donadio, E., Rossi, S., Adinolfi, B., Podestà, A.
Current Medicinal Chemistry. 2009; 16(6): 753-779
[Pubmed]  [Google Scholar]

 

Read this article